Condition: Atrial Fibrillation
Location(s): St. Augustine
Condition: Atrial Fibrillation, Heart Disease
A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulation therapy.
Location(s): St. Augustine
Condition: Atrial Fibrillation, Heart Disease